Susquehanna International Group, LLP Calliditas Therapeutics Ab Transaction History
Susquehanna International Group, LLP
- $527 Billion
- Q2 2024
A detailed history of Susquehanna International Group, LLP transactions in Calliditas Therapeutics Ab stock. As of the latest transaction made, Susquehanna International Group, LLP holds 5,397 shares of CALT stock, worth $215,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,397
Previous 10,277
47.48%
Holding current value
$215,880
Previous $215,000
2.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CALT
# of Institutions
23Shares Held
825KCall Options Held
8.5KPut Options Held
26.6K-
Bvf Inc San Francisco, CA750KShares$30 Million0.89% of portfolio
-
Ironwood Investment Management LLC Boston, MA25.6KShares$1.03 Million0.56% of portfolio
-
Optiver Holding B.V. Amsterdam, P722.3KShares$893,4400.02% of portfolio
-
Ubs Group Ag10.8KShares$430,2400.0% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16KShares$240,0000.2% of portfolio
About Calliditas Therapeutics AB
- Ticker CALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,624,800
- Market Cap $1.06B
- Description
- Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...